Published in Psychopharmacology (Berl) on July 27, 2012
Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment. Neuropharmacology (2013) 0.98
Cellular, molecular, and genetic substrates underlying the impact of nicotine on learning. Neurobiol Learn Mem (2013) 0.93
Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal. Neuropsychopharmacology (2013) 0.84
Habenula cholinergic neurons regulate anxiety during nicotine withdrawal via nicotinic acetylcholine receptors. Neuropharmacology (2016) 0.80
Dissociation of tolerance and nicotine withdrawal-associated deficits in contextual fear. Brain Res (2014) 0.79
Contributions of β2 subunit-containing nAChRs to chronic nicotine-induced alterations in cognitive flexibility in mice. Psychopharmacology (Berl) (2014) 0.78
Comparison of inbred mouse substrains reveals segregation of maladaptive fear phenotypes. Front Behav Neurosci (2014) 0.78
Density of α4β2* nAChR on the surface of neurons is modulated by chronic antagonist exposure. Pharmacol Res Perspect (2015) 0.78
ABT-089, but not ABT-107, ameliorates nicotine withdrawal-induced cognitive deficits in C57BL6/J mice. Behav Pharmacol (2015) 0.77
Donepezil reverses nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6J mice. Behav Neurosci (2014) 0.77
Effects of drugs of abuse on hippocampal plasticity and hippocampus-dependent learning and memory: contributions to development and maintenance of addiction. Learn Mem (2016) 0.77
New mechanisms and perspectives in nicotine withdrawal. Neuropharmacology (2014) 0.77
Bromoenol Lactone Attenuates Nicotine-Induced Breast Cancer Cell Proliferation and Migration. PLoS One (2015) 0.77
Antidepressant-like effects of guanfacine and sex-specific differences in effects on c-fos immunoreactivity and paired-pulse ratio in male and female mice. Psychopharmacology (Berl) (2015) 0.76
Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapies. J Clin Pharm Ther (2014) 0.76
Distinct Roles of CREB within the Ventral and Dorsal Hippocampus in Mediating Nicotine Withdrawal Phenotypes. Neuropsychopharmacology (2016) 0.75
Withdrawal From Chronic Nicotine Reduces Thyroid Hormone Levels and Levothyroxine Treatment Ameliorates Nicotine Withdrawal-Induced Deficits in Hippocampus-Dependent Learning in C57BL/6J Mice. Nicotine Tob Res (2014) 0.75
Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci (1992) 11.73
Are the dorsal and ventral hippocampus functionally distinct structures? Neuron (2010) 6.74
Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology (Berl) (1997) 5.03
Forward: CDC Health Disparities and Inequalities Report - United States, 2011. MMWR Surveill Summ (2011) 4.29
Spatial learning with a minislab in the dorsal hippocampus. Proc Natl Acad Sci U S A (1995) 3.42
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther (2008) 3.17
Hippocampal lesions cause learning deficits in inbred mice in the Morris water maze and conditioned-fear task. Behav Neurosci (1997) 2.65
Smoking withdrawal dynamics in unaided quitters. J Abnorm Psychol (2000) 2.11
Assessment of learning by the Morris water task and fear conditioning in inbred mouse strains and F1 hybrids: implications of genetic background for single gene mutations and quantitative trait loci analyses. Neuroscience (1997) 2.06
Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J Pharmacol Exp Ther (1983) 2.03
Profiles in discouragement: two studies of variability in the time course of smoking withdrawal symptoms. J Abnorm Psychol (1998) 1.84
Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science (1983) 1.78
Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction. Biochem Pharmacol (2009) 1.76
Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography. J Neurochem (2002) 1.75
Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice. J Neurosci (2005) 1.68
Neurobiology of the nicotine withdrawal syndrome. Pharmacol Biochem Behav (2001) 1.67
Behavioral differences among C57BL/6 substrains: implications for transgenic and knockout studies. J Neurogenet (2008) 1.66
Characterization of spontaneous and precipitated nicotine withdrawal in the mouse. J Pharmacol Exp Ther (2003) 1.64
Genetic and behavioral differences among five inbred mouse strains commonly used in the production of transgenic and knockout mice. Genes Brain Behav (2004) 1.63
Nicotine enhancement of contextual fear conditioning. Behav Brain Res (1999) 1.57
Genetic and environmental contributions to smoking. Addiction (1997) 1.55
The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells. J Pharmacol Exp Ther (2004) 1.53
Working memory deficits predict short-term smoking resumption following brief abstinence. Drug Alcohol Depend (2009) 1.53
Strain and substrain differences in context- and tone-dependent fear conditioning of inbred mice. Behav Brain Res (1999) 1.53
Hippocampal alpha4beta2 nicotinic acetylcholine receptor involvement in the enhancing effect of acute nicotine on contextual fear conditioning. J Neurosci (2007) 1.48
Nicotine self-medication of cognitive-attentional processing. Addict Biol (2008) 1.42
Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J Pharmacol Exp Ther (1985) 1.39
Genetic analyses of DSM-IV nicotine withdrawal in adult twins. Psychol Med (2006) 1.32
Nicotine enhances trace cued fear conditioning but not delay cued fear conditioning in C57BL/6 mice. Behav Brain Res (2004) 1.29
Behavioral differences among fourteen inbred mouse strains commonly used as disease models. Comp Med (2005) 1.28
Impact of smoking abstinence on working memory neurocircuitry in adolescent daily tobacco smokers. Psychopharmacology (Berl) (2007) 1.18
Beta2 subunit containing acetylcholine receptors mediate nicotine withdrawal deficits in the acquisition of contextual fear conditioning. Neurobiol Learn Mem (2007) 1.16
Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research. Behav Brain Res (2008) 1.14
Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline. Nicotine Tob Res (2010) 1.13
Nicotine-induced upregulation of native neuronal nicotinic receptors is caused by multiple mechanisms. J Neurosci (2012) 1.12
Genetic approaches identify differential roles for alpha4beta2* nicotinic receptors in acute models of antinociception in mice. J Pharmacol Exp Ther (2007) 1.10
The role of nicotinic acetylcholine receptors in the medial prefrontal cortex and hippocampus in trace fear conditioning. Neurobiol Learn Mem (2010) 1.07
Strain-dependent effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning. Behav Genet (2011) 1.03
Genotype influences the development of tolerance to nicotine in the mouse. J Pharmacol Exp Ther (1991) 1.02
Developmental effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning. Neurobiol Learn Mem (2012) 1.01
Quantitative genetics and mouse behavior. Annu Rev Neurosci (2001) 1.00
Relationship between up-regulation of nicotine binding sites in rat brain and delayed cognitive enhancement observed after chronic or acute nicotinic receptor stimulation. Psychopharmacology (Berl) (1996) 0.99
Hippocampal nAChRs mediate nicotine withdrawal-related learning deficits. Eur Neuropsychopharmacol (2009) 0.96
Survey of embryonic stem cell line source strains in the water maze reveals superior reversal learning of 129S6/SvEvTac mice. Behav Brain Res (2004) 0.96
Nicotine withdrawal disrupts new contextual learning. Pharmacol Biochem Behav (2008) 0.95
Genetics of nicotine response in four inbred strains of mice. J Pharmacol Exp Ther (1983) 0.94
Nicotinic receptors in the dorsal and ventral hippocampus differentially modulate contextual fear conditioning. Hippocampus (2012) 0.93
Fear conditioning in inbred mouse strains: an analysis of the time course of memory. Behav Neurosci (2001) 0.92
The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation. Neuropharmacology (2012) 0.90
All (C57BL/6) Mice are not Created Equal. Front Neurosci (2011) 0.89
Differential learning abilities of 129T2/Sv and C57BL/6J mice as assessed in three water maze protocols. Behav Brain Res (2002) 0.88
Genetic influences on acute responses to nicotine and nicotine tolerance in the mouse. Pharmacol Biochem Behav (1988) 0.87
Sex differences in contextual fear conditioning are associated with differential ventral hippocampal extracellular signal-regulated kinase activation. Neuroscience (2009) 0.84
Cerebellar nicotinic cholinergic receptors are intrinsic to the cerebellum: implications for diverse functional roles. Cerebellum (2011) 0.84
Genetic influences on latent inhibition. Behav Neurosci (1999) 0.81
Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior. Proc Natl Acad Sci U S A (2009) 1.76
cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. J Neurosci (2002) 1.71
Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine. Mol Neurobiol (2008) 1.71
Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice. J Neurosci (2005) 1.68
cAMP response element-binding protein is required for stress but not cocaine-induced reinstatement. J Neurosci (2004) 1.59
OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. Drug Alcohol Depend (2010) 1.55
Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses. Nat Neurosci (2011) 1.53
Hippocampal alpha4beta2 nicotinic acetylcholine receptor involvement in the enhancing effect of acute nicotine on contextual fear conditioning. J Neurosci (2007) 1.48
Mu-opioid receptor and CREB activation are required for nicotine reward. Neuron (2005) 1.45
Dysregulated editing of serotonin 2C receptor mRNAs results in energy dissipation and loss of fat mass. J Neurosci (2008) 1.41
The effects of DHBE and MLA on nicotine-induced enhancement of contextual fear conditioning in C57BL/6 mice. Psychopharmacology (Berl) (2005) 1.39
Genetic evidence for a role of CREB in sustained cortical arousal. J Neurophysiol (2003) 1.37
Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test. Psychopharmacology (Berl) (2005) 1.37
Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. Proc Natl Acad Sci U S A (2011) 1.29
Antidepressant action: to the nucleus and beyond. Trends Pharmacol Sci (2005) 1.24
Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior. J Pharmacol Exp Ther (2010) 1.24
cAMP response element-binding protein deficiency allows for increased neurogenesis and a rapid onset of antidepressant response. J Neurosci (2007) 1.23
The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review. Alcohol Clin Exp Res (2011) 1.18
Beta2 subunit containing acetylcholine receptors mediate nicotine withdrawal deficits in the acquisition of contextual fear conditioning. Neurobiol Learn Mem (2007) 1.16
Endocrine and gene expression changes following forced swim stress exposure during cocaine abstinence in mice. Psychopharmacology (Berl) (2008) 1.14
Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research. Behav Brain Res (2008) 1.14
Nicotine enhances both foreground and background contextual fear conditioning. Neurosci Lett (2005) 1.13
Making a bad thing worse: adverse effects of stress on drug addiction. J Clin Invest (2008) 1.13
Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline. Nicotine Tob Res (2010) 1.13
Molecular and genetic substrates linking stress and addiction. Brain Res (2009) 1.11
Activating transcription factor 1 and CREB are important for cell survival during early mouse development. Mol Cell Biol (2002) 1.11
beta2 subunit-containing nicotinic receptors mediate the enhancing effect of nicotine on trace cued fear conditioning in C57BL/6 mice. Psychopharmacology (Berl) (2006) 1.11
Nicotine enhances context learning but not context-shock associative learning. Behav Neurosci (2008) 1.09
NAC1 regulates the recruitment of the proteasome complex into dendritic spines. J Neurosci (2007) 1.08
Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice. Behav Neurosci (2008) 1.07
Ventral tegmental afferents in stress-induced reinstatement: the role of cAMP response element-binding protein. J Neurosci (2010) 1.06
Effects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety. Neuropharmacology (2009) 1.06
A common single nucleotide polymorphism A118G of the μ opioid receptor alters its N-glycosylation and protein stability. Biochem J (2012) 1.06
Strain-dependent effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning. Behav Genet (2011) 1.03
Neuronal nicotinic acetylcholine receptors: involvement in Alzheimer's disease and schizophrenia. Behav Cogn Neurosci Rev (2002) 1.02
Loss of CDKL5 disrupts kinome profile and event-related potentials leading to autistic-like phenotypes in mice. Proc Natl Acad Sci U S A (2012) 1.02
Developmental effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning. Neurobiol Learn Mem (2012) 1.01
Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain. J Pharmacol Exp Ther (2012) 0.99
Interactive effects of ethanol and nicotine on learning in C57BL/6J mice depend on both dose and duration of treatment. Psychopharmacology (Berl) (2007) 0.99
Stress-induced potentiation of cocaine reward: a role for CRF R1 and CREB. Neuropsychopharmacology (2009) 0.99
Pharmacogenomic evaluation of the antidepressant citalopram in the mouse tail suspension test. Neuropsychopharmacology (2006) 0.99
Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning. Pharmacol Biochem Behav (2007) 0.99
Functional relevance of serotonin 2C receptor mRNA editing in antidepressant- and anxiety-like behaviors. Neuropharmacology (2010) 0.99
CREB gene transcription factors: role in molecular mechanisms of alcohol and drug addiction. Alcohol Clin Exp Res (2005) 0.98
Acute ethanol has biphasic effects on short- and long-term memory in both foreground and background contextual fear conditioning in C57BL/6 mice. Alcohol Clin Exp Res (2007) 0.98
Age-related impairment in the 250-millisecond delay eyeblink classical conditioning procedure in C57BL/6 mice. Learn Mem (2002) 0.97
The effects of acute, chronic, and withdrawal from chronic nicotine on novel and spatial object recognition in male C57BL/6J mice. Psychopharmacology (Berl) (2011) 0.97
Hippocampal nAChRs mediate nicotine withdrawal-related learning deficits. Eur Neuropsychopharmacol (2009) 0.96
Deletion of the GABA(A) receptor alpha1 subunit increases tonic GABA(A) receptor current: a role for GABA uptake transporters. J Neurosci (2006) 0.96
Differential distribution of CREB in the mesolimbic dopamine reward pathway. J Neurochem (2003) 0.96
Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning. Neuropsychopharmacology (2007) 0.96
Gadd45b knockout mice exhibit selective deficits in hippocampus-dependent long-term memory. Learn Mem (2012) 0.96
Behavioral and activity assessment of laboratory mice (Mus musculus) after tail biopsy under isoflurane anesthesia. J Am Assoc Lab Anim Sci (2011) 0.96
Associative learning, the hippocampus, and nicotine addiction. Curr Drug Abuse Rev (2008) 0.95
Nicotine withdrawal disrupts new contextual learning. Pharmacol Biochem Behav (2008) 0.95
The hippocampus and cingulate cortex differentially mediate the effects of nicotine on learning versus on ethanol-induced learning deficits through different effects at nicotinic receptors. Neuropsychopharmacology (2009) 0.94
Inducible cAMP early repressor regulates corticosterone suppression after tricyclic antidepressant treatment. J Neurosci (2004) 0.93
Nicotinic receptors in the dorsal and ventral hippocampus differentially modulate contextual fear conditioning. Hippocampus (2012) 0.93
Augmented responses to morphine and cocaine in mice with a 12-lipoxygenase gene disruption. Psychopharmacology (Berl) (2003) 0.93
Extracellular signal-regulated kinase 1/2 involvement in the enhancement of contextual fear conditioning by nicotine. Behav Neurosci (2007) 0.93
Reward sensitization: effects of repeated nicotine exposure and withdrawal in mice. Neuropsychopharmacology (2012) 0.92
Involvement of hippocampal jun-N terminal kinase pathway in the enhancement of learning and memory by nicotine. Neuropsychopharmacology (2010) 0.92
Nicotine withdrawal disrupts both foreground and background contextual fear conditioning but not pre-pulse inhibition of the acoustic startle response in C57BL/6 mice. Behav Brain Res (2008) 0.92
Reversible inactivation of the entorhinal cortex disrupts the establishment and expression of latent inhibition of cued fear conditioning in C57BL/6 mice. Hippocampus (2007) 0.92
Nicotine ameliorates NMDA receptor antagonist-induced deficits in contextual fear conditioning through high-affinity nicotinic acetylcholine receptors in the hippocampus. Neuropharmacology (2010) 0.91
The interactive effects of nicotinic and muscarinic cholinergic receptor inhibition on fear conditioning in young and aged C57BL/6 mice. Pharmacol Biochem Behav (2004) 0.91
Selective deletion of a cell cycle checkpoint kinase (ATR) reduces neurogenesis and alters responses in rodent models of behavioral affect. Neuropsychopharmacology (2011) 0.89
Differential effects of acute and repeated citalopram in mouse models of anxiety and depression. Int J Neuropsychopharmacol (2009) 0.89
Effects of ethanol and caffeine on behavior in C57BL/6 mice in the plus-maze discriminative avoidance task. Behav Neurosci (2009) 0.88
Cocaine-related behaviors in mice with deficient gliotransmission. Psychopharmacology (Berl) (2012) 0.88
Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats. Neuropsychopharmacology (2012) 0.88
Regulation of antidepressant activity by cAMP response element binding proteins. Mol Neurobiol (2004) 0.87
Alterations in morphine-induced reward, locomotor activity, and thermoregulation in CREB-deficient mice. Brain Res (2005) 0.87
Decreased CREB levels suppress epilepsy. Neurobiol Dis (2011) 0.86
Sex differences in response to nicotine in C57Bl/6:129SvEv mice. Nicotine Tob Res (2009) 0.86
Targeted deletion of the mouse α2 nicotinic acetylcholine receptor subunit gene (Chrna2) potentiates nicotine-modulated behaviors. J Neurosci (2013) 0.86
Effects of chronic low- and high-dose nicotine on cognitive flexibility in C57BL/6J mice. Behav Brain Res (2012) 0.86
Rolipram attenuates MK-801-induced deficits in latent inhibition. Behav Neurosci (2005) 0.86
Increased hippocampal neurogenesis and accelerated response to antidepressants in mice with specific deletion of CREB in the hippocampus: role of cAMP response-element modulator τ. J Neurosci (2013) 0.85
Malleability in the development of spatial reorientation. Dev Psychobiol (2012) 0.85
Of mice (Mus musculus) and toddlers (Homo sapiens): evidence for species-general spatial reorientation. J Comp Psychol (2009) 0.85
Extrasynaptic targeting of NMDA receptors following D1 dopamine receptor activation and cocaine self-administration. J Neurosci (2013) 0.85
Parkinson's disease-like neuromuscular defects occur in prenyl diphosphate synthase subunit 2 (Pdss2) mutant mice. Mitochondrion (2011) 0.85
The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice. Behav Brain Res (2011) 0.85
Depressive phenotypes evoked by experimental diabetes are reversed by insulin. Physiol Behav (2011) 0.84
Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal. Neuropsychopharmacology (2013) 0.84
Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice. Neurobiol Learn Mem (2008) 0.83
Requirement for the POZ/BTB protein NAC1 in acute but not chronic psychomotor stimulant response. Behav Brain Res (2007) 0.83
Reactivation of cocaine reward memory engages the Akt/GSK3/mTOR signaling pathway and can be disrupted by GSK3 inhibition. Psychopharmacology (Berl) (2014) 0.82
The enhancement of contextual fear conditioning by ABT-418. Behav Pharmacol (2010) 0.82
Interactive effects of ethanol and nicotine on learning, anxiety, and locomotion in C57BL/6 mice in the plus-maze discriminative avoidance task. Neuropharmacology (2009) 0.82
Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors. J Pharmacol Exp Ther (2014) 0.82
Brain region- and sex-specific alterations in DAMGO-stimulated [(35) S]GTPγS binding in mice with Oprm1 A112G. Addict Biol (2012) 0.82
μ-Opioid receptor availability in the amygdala is associated with smoking for negative affect relief. Psychopharmacology (Berl) (2012) 0.82